Form 4: Vita Coco Executive Chairman Sells Shares Under 10b5-1 Plan
Insider Transaction Report
Michael Kirban, Executive Chairman of Vita Coco Company, Inc., sold 5,102 shares of common stock for $44 per share as part of a pre-arranged Rule 10b5-1 trading plan.
Summary
- Michael Kirban, Executive Chairman of Vita Coco Company, Inc. (COCO), reported the sale of 5,102 shares of common stock.
- The transaction occurred on November 14, 2025, at a price of $44 per share.
- The sale was executed pursuant to a Rule 10b5-1 trading plan, indicating a pre-scheduled transaction.
- Following this transaction, Kirban directly holds 127,629 shares of common stock.
- He also indirectly holds 1,479,049 shares through the Michael Kirban 2010 Trust and 615,681 shares through the Michael Kirban Revocable Trust.
- Kirban maintains beneficial ownership of various non-qualified stock options, including 546,000 options exercisable at $10.178, 40,950 options exercisable at $10.178, 298,507 options exercisable at $15, 46,875 options exercisable at $16.91, 62,743 options exercisable at $26.18, and 70,715 options exercisable at $32.78.
Sentiment
Score: 5
Explanation: The sentiment is neutral. While an insider sale can sometimes be viewed negatively, the transaction was conducted under a Rule 10b5-1 plan, which indicates it was pre-scheduled and not a reaction to immediate news. The volume of shares sold is also relatively small compared to the insider's total holdings.
Positives
- The sale was conducted under a Rule 10b5-1 trading plan, which suggests the transaction was pre-scheduled and not based on immediate, non-public information.
Negatives
- An insider sale, even under a 10b5-1 plan, can sometimes be perceived by investors as a neutral to slightly negative signal regarding management's near-term outlook for the company, although the amount sold is a small fraction of total holdings.
Future Outlook
This filing does not contain specific forward-looking statements or guidance regarding the company's future performance.
Industry Context
This insider transaction report provides specific details about a director's stock activity and does not offer broader industry context or trends.
Stakeholder Impact
- Shareholders may interpret the insider sale with caution, although the Rule 10b5-1 plan mitigates concerns that the sale is based on adverse non-public information.
Key Dates
| Date | Description |
|---|---|
| 11/27/2022 | Start of vesting for a non-qualified stock option with an exercise price of $15. |
| 03/10/2024 | Start of vesting for a non-qualified stock option with an exercise price of $16.91. |
| 03/04/2025 | Start of vesting for a non-qualified stock option with an exercise price of $26.18. |
| 11/14/2025 | Date of common stock transaction (sale) by Michael Kirban. |
| 11/17/2025 | Signature date of the reporting person for the Form 4 filing. |
| 03/03/2026 | Start of vesting for a non-qualified stock option with an exercise price of $32.78. |
| 12/16/2029 | Expiration date for a fully vested non-qualified stock option with an exercise price of $10.178. |
| 01/11/2031 | Expiration date for a fully vested non-qualified stock option with an exercise price of $10.178. |
Keywords
Vita Coco, COCO, Michael Kirban, Insider Trading, Form 4, Stock Sale, Rule 10b5-1, Executive Chairman
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.